Meta pivots Reality Labs to smart glasses dominance/AI pods/Quest decline; Horizon wind-down & privacy suits; Ray-Ban Blazer expansion + accessibility PR + SDK apps; +4% stock surge
Key Questions
What is Meta's pivot in Reality Labs?
Reality Labs is pivoting to smart glasses dominance and AI pods, with Quest declining -42% and $19.1B burn. Horizon is winding down amid 30%+ layoffs (700+).
How are Ray-Ban Meta smart glasses performing?
Ray-Ban glasses hold 76% XR share, with 7M units sold; Gen2 at $499 launches in Japan with AI pre-orders. Expansions include prescription models via Scriber and Ray-Ban Blazer.
What apps are available for Meta's smart glasses?
SDK apps include hide-and-seek, plant ID, study cam, and accessibility like Aira for the blind (e.g., powering a marathon runner). Orion AR demos showcase potential.
What is the status of Quest headsets?
Quest sales dropped -42%, with Quest4 leaks suggesting improvements challenging Apple Vision Pro. VR relevance in 2026 is questioned amid metaverse retreat.
What financial impact has Reality Labs had?
Reality Labs burned $19.1B, contributing to Zuckerberg's $80B metaverse loss. Heavy spending weighs on investor sentiment alongside privacy suits.
What privacy and legal issues face Meta's XR?
Privacy suits and trial losses add to challenges, with 30%+ RL layoffs. Horizon shutdown reflects strategic retreat.
How is Meta expanding smart glasses accessibility?
New prescription Ray-Ban Meta Optics with EssilorLuxottica target billions of eyewear users. Apps like 'Be My Eyes' aid visually impaired users.
What is the future of Meta's Quest?
Quest4 leaks indicate enhancements, but overall Quest decline and Horizon wind-down signal focus shift to glasses/AI. Q1 results will clarify RL burn and legal outlook.
XR +44% glasses (Ray-Ban 76%/7M hit/$499 Gen2/Scriber prescription/Japan/AI pre-order/SDK apps: hide-and-seek/plant ID/study cam/accessibility Aira/OOrion, drove +4% to $558); Quest -42%/$19.1B burn/Horizon shutdown/Quest4 leaks; RL layoffs 30%+/700; privacy suits ($80B flop).